bpc 157 and tb 500 together BPC-157 & TB-500 - 10MG/20MG BPC157 & TB500 Blend (10mg/10mg)

Commonly Reported Side Effects Fatigue or lethargy (typically within the first week) Headaches or mild brain fog Dizziness or a drop in blood pressure Temporary injection site irritation Increased thirst or urination Some users report vivid dreams or changes in sleep patterns, though this is more common with compounds like MK-677 and HGH

Tirzepatide adds a second target, the GIP receptor, activating a dual pathway that supports fat metabolism and insulin sensitivity on top of appetite reduction

NAD+ Injections: The Cellular Rejuvenation Boost NAD+ (Nicotinamide Adenine Dinucleotide) injections are a powerhouse for cellular health

1,2,6 Symptoms typically include being easily fatigued with exertion, palpitations, and skin pallor

Central Standard Time [CST])

peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events